Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

120 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Inhibiting the P2Y12 Receptor in Megakaryocytes and Platelets Suppresses Interferon-Associated Responses.
Sowa MA, Sun H, Wang TT, Virginio VW, Schlamp F, El Bannoudi H, Cornwell M, Bash H, Izmirly PM, Belmont HM, Ruggles KV, Buyon JP, Voora D, Barrett TJ, Berger JS. Sowa MA, et al. Among authors: belmont hm. JACC Basic Transl Sci. 2024 Jul 24;9(9):1126-1140. doi: 10.1016/j.jacbts.2024.05.014. eCollection 2024 Sep. JACC Basic Transl Sci. 2024. PMID: 39444926 Free PMC article.
ANA-positive versus ANA-negative Antiphospholipid Antibody-positive Patients: Results from the APS ACTION Clinical Database and Repository.
Cecchi I, Radin M, Foddai SG, Barinotti A, Andrade D, Tektonidou MG, Pengo V, Ruiz-Irastorza G, Belmont HM, Lopez Pedrera C, Fortin PR, Gerosa M, de Jesus G, Atsumi T, Ji L, Efthymiou M, Branch DW, Nalli C, Rodriguez-Almaraz E, Petri M, Cervera R, Knight J, Artim-Esen B, Willis R, Bertolaccini ML, Cohen H, Erkan D, Sciascia S. Cecchi I, et al. Among authors: belmont hm. Rheumatology (Oxford). 2024 Oct 18:keae583. doi: 10.1093/rheumatology/keae583. Online ahead of print. Rheumatology (Oxford). 2024. PMID: 39423147
Prevalence of cardiovascular events in a population-based registry of patients with systemic lupus erythematosus.
Joyce DP, Berger JS, Guttmann A, Hasan G, Buyon JP, Belmont HM, Salmon J, Askanase A, Bathon J, Geraldino-Pardilla L, Ali Y, Ginzler EM, Putterman C, Gordon C, Helmick CG, Barbour KE, Gold HT, Parton H, Izmirly PM. Joyce DP, et al. Among authors: belmont hm. Arthritis Res Ther. 2024 Sep 14;26(1):160. doi: 10.1186/s13075-024-03395-6. Arthritis Res Ther. 2024. PMID: 39272198 Free PMC article.
Association of Autoantibody Concentrations and Trajectories With Lupus Nephritis Histologic Features and Treatment Response.
Fava A, Wagner CA, Guthridge CJ, Kheir J, Macwana S, DeJager W, Gross T, Izmirly P, Belmont HM, Diamond B, Davidson A, Utz PJ, Weisman MH, Magder LS; Accelerating Medicines Partnership Rheumatoid Arthritis and Systemic Lupus Erythematosus (AMP RA/SLE) Network; Guthridge JM, Petri M, Buyon J, James JA. Fava A, et al. Among authors: belmont hm. Arthritis Rheumatol. 2024 Nov;76(11):1611-1622. doi: 10.1002/art.42941. Epub 2024 Aug 9. Arthritis Rheumatol. 2024. PMID: 38962936
Extrarenal symptoms associate with worse quality of life in patients enrolled in the AMP RA/SLE Lupus Nephritis Network.
Carlucci PM, Preisinger K, Deonaraine KK, Zaminski D, Dall'Era M, Gold HT, Kalunian K, Fava A, Belmont HM, Wu M, Putterman C, Anolik J, Barnas JL, Furie R, Diamond B, Davidson A, Wofsy D, Kamen D, James JA, Guthridge JM, Apruzzese W, Rao D, Weisman MH; Accelerating Medicines Partnership in RA/SLE Network; Izmirly PM, Buyon J, Petri M. Carlucci PM, et al. Among authors: belmont hm. Rheumatology (Oxford). 2024 Mar 26:keae189. doi: 10.1093/rheumatology/keae189. Online ahead of print. Rheumatology (Oxford). 2024. PMID: 38530774
Prevalence of concomitant rheumatologic diseases and autoantibody specificities among racial and ethnic groups in SLE patients.
Denvir B, Carlucci PM, Corbitt K, Buyon JP, Belmont HM, Gold HT, Salmon JE, Askanase A, Bathon JM, Geraldino-Pardilla L, Ali Y, Ginzler EM, Putterman C, Gordon C, Barbour KE, Helmick CG, Parton H, Izmirly PM. Denvir B, et al. Among authors: belmont hm. Front Epidemiol. 2024 Mar 6;4:1334859. doi: 10.3389/fepid.2024.1334859. eCollection 2024. Front Epidemiol. 2024. PMID: 38516120 Free PMC article.
Longitudinal patterns and predictors of response to standard-of-care therapy in lupus nephritis: data from the Accelerating Medicines Partnership Lupus Network.
Izmirly PM, Kim MY, Carlucci PM, Preisinger K, Cohen BZ, Deonaraine K, Zaminski D, Dall'Era M, Kalunian K, Fava A, Belmont HM, Wu M, Putterman C, Anolik J, Barnas JL, Diamond B, Davidson A, Wofsy D, Kamen D, James JA, Guthridge JM, Apruzzese W, Rao DA, Weisman MH; Accelerating Medicines Partnership in RA/SLE Network; Petri M, Buyon J, Furie R. Izmirly PM, et al. Among authors: belmont hm. Arthritis Res Ther. 2024 Feb 20;26(1):54. doi: 10.1186/s13075-024-03275-z. Arthritis Res Ther. 2024. PMID: 38378664 Free PMC article.
Urine proteomic signatures of histological class, activity, chronicity, and treatment response in lupus nephritis.
Fava A, Buyon J, Magder L, Hodgin J, Rosenberg A, Demeke DS, Rao DA, Arazi A, Celia AI, Putterman C, Anolik JH, Barnas J, Dall'Era M, Wofsy D, Furie R, Kamen D, Kalunian K, James JA, Guthridge J, Atta MG, Monroy Trujillo J, Fine D, Clancy R, Belmont HM, Izmirly P, Apruzzese W, Goldman D, Berthier CC, Hoover P, Hacohen N, Raychaudhuri S, Davidson A, Diamond B; Accelerating Medicines Partnership in RA/SLE network; Petri M. Fava A, et al. Among authors: belmont hm. JCI Insight. 2024 Jan 23;9(2):e172569. doi: 10.1172/jci.insight.172569. JCI Insight. 2024. PMID: 38258904 Free PMC article.
120 results